JAK3, JAK2, JAK2/FLT3 IN 1, JAK2/FLT3IN1, JAK-2/FLT3-IN-1, JAK2/FLT3-IN-1, JAK1, FLT3
Flonoltinib is an orally bioavailable, potent inhibitor of JAK2 and FLT3 with additional activity against JAK1 and JAK3. It is used in research for myeloproliferative neoplasms, demonstrating anti-cancer effects in both cellular assays and in vivo models.